LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

10.18632/oncotarget.25835

Saved in:
Bibliographic Details
Main Authors: Hee, Y.T, Yan, J, Nizetic, D, Chng, W.-J
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2020
Subjects:
cyclin dependent kinase 4
cyclin dependent kinase 6
Janus kinase 1
Janus kinase 2
ribociclib
ruxolitinib
STAT protein
Article
cancer combination chemotherapy
cancer inhibition
cell cycle progression
cell viability
controlled study
drug efficacy
drug potentiation
drug targeting
enzyme inhibition
IC50
lymphoma cell line
monotherapy
NK T cell lymphoma
Online Access:https://scholarbank.nus.edu.sg/handle/10635/178073
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/178073

Similar Items